Stock Comparison
INSM vs VRTX
Insmed Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$22.41B
$124.70B
P/E (TTM)
—
29.2
Forward P/E
16.4
25.8
Price/Sales
27.3
10.2
Price/Book
31.8
6.4
EV/EBITDA
-6.1
24.0
Dividend Yield
—
—
Profitability
Net Margin
-144.40%
35.50%
Operating Margin
-65.50%
38.10%
Return on Equity
-294.50%
24.20%
Return on Assets
-31.10%
12.10%
Growth (YoY)
Revenue Growth
229.60%
7.80%
Earnings Growth
0.00%
61.40%
Price & Risk
Beta
0.8
0.3
52-Week High
$212.75
$507.92
52-Week Low
$90.39
$362.50
Analyst Target
$197.05
$548.69
Compare INSM and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.